Perrigo Co. Plc
(NYSE : PRGO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
2.51%14.7014.1%$263.94m
SHPGShire PLC Sponsored ADR
1.89%147.370.4%$196.60m
PRGOPerrigo Co. Plc
-1.35%85.836.6%$138.72m
MNKMallinckrodt Plc
-0.31%22.3818.5%$115.94m
SAGESAGE Therapeutics, Inc.
0.01%85.6811.9%$89.57m
JAZZJazz Pharmaceuticals Plc
0.26%133.872.2%$75.98m
ENDPEndo International Plc
3.29%7.548.9%$65.52m
ICPTIntercept Pharmaceuticals, Inc.
1.39%60.7322.0%$53.20m
UTHRUnited Therapeutics Corporation
1.15%123.0214.5%$49.84m
PCRXPacira Pharmaceuticals, Inc.
1.90%40.2510.7%$40.63m
MDCOMedicines Company
1.32%31.4322.1%$38.62m
ICLRICON Plc
1.36%117.254.1%$37.65m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-1.42%115.887.6%$35.91m
ADMSAdamas Pharmaceuticals, Inc.
2.60%28.4116.9%$33.20m
PTLAPortola Pharmaceuticals, Inc.
0.26%49.287.8%$33.10m

Company Profile

Perrigo Co. Plc engages in the production of over-the-counter consumer goods and specialty pharmaceutical products. It operates through the following segments: Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals, and Specialty Sciences. The CHC segment includes the company's former segments, which are the Nutritionals and Israel Pharmaceuticals and Diagnostics business. The BCH segment consists of the Omega business. The Prescription Pharmaceuticals includes the Rx Pharmaceuticals business. The Specialty Sciences segment comprises of the assets, which focuses on the treatment of multiple sclerosis. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland.